Poster 34

Trazodone prescribing in insomnia: a real-world cohort study

William Vaughn McCall , Elaine Liu

Presented at Psych Congress 2022

Abstract: Trazodone is indicated for depressive disorder (150-400 mg/day) but is often prescribed off-label to treat insomnia at “low dose” (

Popular Now

News

FDA Approves First Schizophrenia Treatment in Over 3 Decades

09/27/2024

Meagan Thistle ;

The US Food and Drug Administration (FDA) has approved Cobenfy (xanomeline and trospium chloride) capsules for oral use for the treatment of schizophrenia in adults.

The US Food and Drug...

09/27/2024

Psych Congress Network

Q&A

Clinicians Should Set Realistic Expectations for Telehealth Treatment

06/28/2021

Onboarding patients to telepsychiatry includes setting realistic expectations for both the patient and provider and ensuring the patient is comfortable with the platform, says Edward Kaftarian, MD.

Onboarding patients to...

06/28/2021

Psych Congress Network

The Use of Benzodiazepines in Patients With Anxiety Disorders

09/30/2021

In this podcast, Manish Jha, MD, discusses common clinical questions surrounding the use of benzodiazepines in patients with anxiety disorders.

In this podcast, Manish Jha, MD,...

09/30/2021

Psych Congress Network

BHE Podcast

BHE Podcast, Episode 033 – Nate Hartmann, Corporate VP of Operations for Symetria Recovery

01/27/2023

Symetria Recovery Corporate Vice President of Operations Nate Hartmann joins the BHE Podcast to discuss how behavioral healthcare organizations can build and maintain a strong workforce.

Symetria Recovery Corporate Vice...

01/27/2023

Behavioral Healthcare Executive

Q&A

Keeping Telepsychiatry HIPAA Compliant

07/13/2021

Clinicians who use telepsychiatry should remain diligent in staying HIPAA compliant post COVID-19.

Trazodone prescribing in insomnia: a real-world cohort study

Popular Now

Sign Up

Specialties

Events

Year Round Education

HMP Global Products